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ABSTRACT
Spermatogenesis is a highly regulated process that involves both mitotic and meiotic divisions, as well as cellular
differentiation to yield mature spermatozoa from undifferentiated germinal stem cells.  Although  Gpat2 was
originally annotated as a glycerol-3-phospate acyltransferase by sequence homology to Gpat1, GPAT2 is highly
expressed in testis but not in lipogenic tissues and is not up-regulated during adipocyte differentiation.  New
data show that GPAT2 is required for the synthesis of piRNAs, a group of small RNAs that protect the germ cell
genome from retrotransposable elements.  In order to understand the relationship between GPAT2 and its role
in  the  testis,  we  focused  on  Gpat2 expression  during  the  first  wave  of  mouse  spermatogenesis.   Gpat2
expression was analyzed by qPCR, in situ hybridization, immunohistochemistry and Western blot.  Gpat2 mRNA
content and protein expression were maximal at 15 dpp and restricted to pachytene spermatocytes.  To achieve
this transient expression, both epigenetic mechanisms and trans-acting factors are involved.  In vitro assays
showed that  Gpat2 expression correlates with DNA demethylation and histone acetylation and that it is up-
regulated by retinoic acid.  Epigenetic regulation by DNA methylation was confirmed in vivo in germ cells by
bisulfite sequencing of the  Gpat2 promoter.  Consistent with the initiation of meiosis at 11 dpp, methylation
decreased dramatically.  Thus, Gpat2 is expressed at a specific stage of spermatogenesis, consistent with piRNA
synthesis  and  meiosis  I  prophase,  and  its  on-off  expression  pattern  responds  predominantly  to  epigenetic
modifications.
Summary statement 
We studied the expression pattern and the mechanisms governing the transcription of Gpat2, an enzyme that is
highly expressed in testis.  GPAT2 is regulated epigenetically and its expression correlates with the initiation of
meiosis.
Short title (up to 75 characters)
Gpat2 regulation during the first wave of spermatogenesis.
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GPAT2, meiosis, epigenetic regulation, retinoic acid.
Abbreviation list
piRNA: PIWI interacting RNA
GPAT: Glycerol-3-phosphate acyltransferase 
LPA: lysophosphatidic acid 
CTs: cancer-testis genes 
DMEM: Dulbecco's Modified Eagle Medium 
Dpp: days post-partum
fRMA: frozen robust multi-array analysis 
IBMX: isobutylmethylxanthine 
DAC: 5-aza-2-deoxycitidine 
TSA: trichostatin A
SAM: S-adenosylmethionine 
VDAC: voltage dependent anion channel 
ISH: in situ mRNA hybridization 
Dpc: days post coitum 
IHC: immunohistochemistry 
TSS: transcription start site 
RA: retinoic acid 
ATRA: all-trans RA 
INTRODUCTION
Spermatogenesis is a highly regulated process that involves both mitotic and meiotic divisions, as well as
cellular differentiation to yield mature spermatozoa from undifferentiated germinal stem cells.  The endocrine
regulation of spermatogenesis occurs through the combined action of hormones and growth factors, including
the effects of  retinoic acids, which are vitamin A derivatives essential for meiosis initiation  [1,2].  Epigenetic
modifications and chromatin remodeling are also important regulators in spermatogenesis [3].  PIWI interacting
RNAs (piRNAs) are small non-coding RNAs synthesized in germ cells, where they are believed to repress the
expression of deleterious retrotransposons, thereby ensuring genome integrity during meiosis [4].  In mice these
small non-coding RNAs interact with the Argonaute family proteins (Ago and Piwi clades of proteins), such as
MIWI,  MILI  and  MIWI2  members,  which  also  participate  in  piRNA  biogenesis.   Glycerol-3-phosphate
acyltransferase-2 (GPAT2) was unexpectedly found to be required for  piRNA biogenesis.  The knockdown of
Gpat2  in  germline stem cells  impairs  primary piRNA production, and it  was shown that the GPAT2 protein
physically interacts with MILI in both germline stem cells and mouse testis.  The mechanism by which GPAT2
promotes piRNA production remains unknown, but because this function occurs despite the absence of the
acyltransferase motif, H(X4)D, the regulation of piRNA production by GPAT2 is unlikely to require acyltransferase
enzymatic activity [5].
GPAT isoforms catalyze the first and rate-limiting step in  de novo glycerolipid biosynthesis, acylating
glycerol-3-phospate with a long-chain fatty acyl-CoA to form lysophosphatidic acid (LPA).  LPA is the substrate
for 1-acylglycerol-3-phosphate acyltransferase which catalyzes the formation of phosphatidic acid, the precursor
for triacylglycerol and glycerophospholipid biosynthesis.  In mammals, four GPAT isoforms (GPAT 1-4) have been
described  which  differ  in  their  subcellular  locations,  tissue  expression  pattern,  substrate  preference,
transcriptional regulation, and sensitivity to sulfhydryl group reagents such as N-ethylmaleimide [6].  GPAT1 and
GPAT2  are  mitochondrial  isoforms  whereas  GPAT3  and  GPAT4  are  located  in  the  endoplasmic  reticulum.
GPAT1, 3 and 4 are highly expressed in lipogenic tissues such as liver and adipose tissue where they initiate the
de novo synthesis of triacylglycerol and glycerophospholipids  [6].  During adipocyte differentiation of 3T3-L1
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fibroblasts, the expression of these three isoforms increases;  Gpat1 and 4 are moderately induced (10- and 5-
fold, respectively) in differentiated adipocytes and Gpat3 is highly induced (>60-fold) [7-9].  In contrast, Gpat2
mRNA expression is not regulated by nutritional status, and it is at least 50-fold higher in testis than in any other
tissue [10].  
GPAT2 also differs from the other GPAT isoforms in that it belongs to a group of genes named “cancer-
testis genes” (CTs).  CTs are important at specific stages during spermatogenesis, but are expressed at low levels
or not expressed at all in somatic tissues.  CTs are ectopically overexpressed in cancers from different locations,
and contribute to the tumor phenotype [11,12].  We have shown that human GPAT2 is overexpressed in several
types  of  cancer  and  in  cancer-derived  human  cell  lines,  and  that  its  expression  contributes  to  the  tumor
phenotype, because in tumor cells with diminished GPAT2 expression, the proliferation and migration rates are
lower, and in mouse xenograft models, cells with diminished GPAT2 expression have lower tumorigenicity [13]. 
To understand the physiological role of GPAT2 in the testis, we focused on its developmental regulation
during spermatogenesis   Our data show that  Gpat2 is expressed at a specific stage of the spermatogenesis,
consistent with meiosis I prophase, and that its on-off expression pattern responds predominantly to epigenetic
modifications and probably to retinoic acid signaling. 
MATERIALS AND METHODS
Chemicals
All chemicals were purchased from Sigma unless otherwise indicated.
Animals, cell lines and culture conditions
Animal protocols were approved by the Facultad de Ciencias Médicas, Universidad Nacional de La Plata
Institutional Animal Care and Use Committee (Approval Number T10-02-2013).  Male BALB/c mice were housed
on a 12/12-h light/dark cycle with free access to water and Cargill Rodent chow.  Before testis dissections, mice
were euthanized in a CO2 chamber.  Cells were purchased from ATCC and were grown at 37 °C in a 5% CO2
atmosphere with a 98% relative humidity.  The hamster cell line CHO-K1 was maintained in F12 (Gibco) medium,
the mouse macrophage cell line RAW 264.7 and the embryonic fibroblast 3T3-L1 mouse cell line in Dulbecco's
Modified Eagle´s Medium (DMEM) (Gibco),  the human breast cancer cell line derived from metastatic pleural
effusion  MCF7  in  RPMI-1640  medium  (Gibco) and  the  mouse  Sertoli  cell  line  TM4 in  DMEM/F12  medium
(Gibco).   All  media were supplemented with 10 % FBS and antibiotics (50 units/ml  penicillin  and 50 μg/ml
streptomycin).
Analysis of mRNA transcription 
Total RNA from Balb/c mouse testes at 3, 7, 11, 15, 20, 35, and 50 days post-partum (dpp), RAW 264.7
and 3T3L1 cells was isolated with TRIzol Reagent (Invitrogen) according to the manufacturer’s instructions.  RNA
quality was determined by gel electrophoresis and 260/230 and 260/280 nm absorbance ratios.  One µg of total
RNA was used for cDNA synthesis employing the High Capacity Reverse Transcription Kit (Applied Biosystems).  A
1/15 cDNA dilution was used for the qPCR reaction with ABsolute QPCR SYBR Green Mix (Thermo).  Primers
were designed to amplify a fragment of 187 bp between exon 16 (forward primer: ATCCTACTGCTGCTGCACCT)
and exon 18 (reverse primer: ACAGCAGCTTTGCACTCAGA) of the mouse Gpat2 transcript.  The thermal profile
was 95°C for 15 min, followed by 40 cycles of 95 °C for 30 s, 55 °C for 1 min and 72 °C for 30 s, on a Stratagene
Mx3000P apparatus.  RNA expression was quantified in duplicate using the ΔΔCt method, and each sample was
normalized to two different housekeeping genes: Gapdh (forward primer: CTGGAGAAACCTGCCAAGTA; reverse
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primer: TGTTGCTGTAGCCCGTATTCA) and Rpl13a (forward primer: ATGACAAGAAAAAGCGGATG; reverse primer:
CTTTTCTGCCTGTTTCCGTA) using qBase software.
In silico evaluation of mouse Gpat2 expression
To validate experimental results regarding  Gpat2 mouse expression profile during testis development,
microarray data from pre and post-natal ages were collected to construct a box plot graphic.  Gene expression
information was  obtained from GSE4818 (n=21,  mouse  testis  prenatal  development)  and GSE12769  (n=20,
mouse testis postnatal development) datasets, both developed in the Affymetrix genechip mouse genome 430
2.0 platform (Mouse430_2).  To generate a homogeneous dataset in fetal and adult mouse testes, the frozen
robust multi-array analysis (fRMA) package from Bioconductor (http://www.bioconductor.org/) was employed.
The fRMA preprocessing algorithm allows the analysis of independent oligo-microarray studies/batches, and
then combines the data for further statistical analysis.  Gpat2 mRNA expression level was estimated by using the
expression values of the Affymetrix probe 1456208_AT.
In situ hybridization
Riboprobes for in situ hybridization were prepared by digesting mouse Gpat2 cDNA from the pcDNA3.1-
Gpat2 construct at the BamHI and EcoRI sites and subcloning the 1456 bp fragment into pGEM11z(f)+ vector
(Promega).   The tissue preparation, probe synthesis,  and hybridization were performed at the University of
North  Carolina  at  Chapel  Hill  Neuroscience  Center  Molecular  Neuroscience  Core  Facility
(http://www.med.unc.edu/neuroscience/core-facilities/molecular-neuroscience).  Testes from 7, 15 and 30 dpp
mice were fixed in 4% paraformaldehyde in 0.1 M PBS, and processed as previously described [14].  Slides were
visualized in an Olympus BX52 microscope.
Immunohistochemistry analysis
Testes from 7, 15, 30 and 40 dpp mice were fixed in Bouin’s solution in the same paraffin block, and 4
µm sections were cut.  Samples were processed as previously described [14].  Slides were counter-stained with
haematoxylin to visualize the nuclei and analyzed with an Olympus BX52 microscope.
3T3-L1 differentiation assay
3T3-L1  cells  were  seeded  in  12  well  plates  and  grown  in  routine  medium  until  confluence,  then
stimulated with 2 µg/ml insulin, 0.25 µM dexamethasone and 0.5 mM isobutylmethylxanthine (IBMX) [15].  Full
differentiation was achieved on day 8.  RNA (triplicate samples) was isolated with TRIzol reagent at different
times: 0 h, 12 h, 18 h, 24 h, 36 h, 48 h , 96 h, 144 h and 192 h.  One µg was used for cDNA synthesis, and Gpat2
content was evaluated by qPCR. 
Cloning of Gpat2 gene promoter regions
Primer pairs were used to amplify different regions of the putative Gpat2 promoter upstream of the ATG
start codon from mouse genomic DNA; all included a terminal MluI (forward primer) or HindIII (reverse primer)
restriction  sites.   Forward  primers:  -1324P  fragment  (-1324/+2105)  ACGCGTGGTTCTGAAACTGGAGGTCAG,
-1165P  fragment (-1165/+2105)  ACGCGTGACCAGGAGAGGGTGCTAGA,  -873P  fragment (-873/+2105)
ACGCGTACAGCTGACCAAAAGCCACT,  -642P  fragment (-642/+2105)  ACGCGTTGGGGTAATTGGTTCTCACC,  -156P
fragment (-156/+2105)  ACGCGTTGTGGTACAGGCAGCAAGTC  and  +165P  fragment  (+165/+2015)
ACAGTCAGAGGCAAGCTGGT.  The reverse  primer  was  AAGCTTTCTGTAAGATCAGTGAATCAAGCAC.   To test  for
possible downstream regulation, the first non-translated exon of  Gpat2 mRNA as well as the first intron were
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included in the promoter constructs  [16].   All  five fragments were amplified using iProof  High-Fidelity DNA
Polymerase (BioRad), double digested with MluI and HindIII, and ligated into the pGL3-Basic Vector (Promega).
All plasmids were prepared using the Plasmid Miniprep kit (Qiagen), quantified by UV spectrophotometry, and
sequenced.
Cell transfection, hormone response evaluation and luciferase assay
To  study  basal  promoter  activity,  CHO-K1  cells  were  seeded  in  a  24-well  plate.   The  next  day
Lipofectamine 2000 (Invitrogen) was used to co-transfect 0.5 µg/ well of each pGL3 construct with 0.05 µg/ well
of pRL-Renilla Luciferase Reporter Vector (Renilla).   Thirty-six  h after transfection, cells  were harvested and
lysed,  and  luciferase  activity  was  measured  using  the  Dual  Luciferase  Reporter  Assay  System  (Promega).
Relative luciferase activity was normalized by the Renilla luciferase activity.  To evaluate the hormone response,
CHO-K1, MCF7 or TM4 cells were seeded in a 48-well plate 24 h before Lipofectamine 2000 co-transfection with
1.14  µg/well  of  pGL3  constructs  and  0.11  µg/well  of  Renilla  luciferase plasmid.   Five  h  after  transfection,
medium with hormones and lacking FBS, was added to the cells.  The next day, the medium was replaced with
fresh medium and hormones.  Forty-eight h after transfection, cells were harvested and lysed, and luciferase
activity was measured as described above.  All experiments were performed in duplicate and repeated at least
twice.  Hormones  tested  (concentration  range  is  indicated  between  brackets):  estradiol  (0.1-10  nM),
corticosterone (0.1-0.2 µM), all-trans retinoic acid (ATRA) (2-20 µM) and 9-cis-retinoic acid (9cisRA) (2-8 µM). 
DAC and TSA treatments
The  effect  of  the  DNA  methyltransferase  inhibitor  5-aza-2-deoxycitidine  (DAC)  and  the  histone
deacetylase inhibitor Trichostatin A (TSA) on  Gpat2 transcription was studied in RAW 264.7 cells.  Cells were
seeded in a 12-well plate to reach 20% confluence.  The next day, the medium was changed, and cells were
treated with  2 µM DAC (for  “DAC” and “TSA+DAC” treatments)  or  DMSO (control).   Media  and DAC were
replaced every 24 h for 3 days.  Five-hundred nM TSA was added on the fourth day (“TSA” and “TSA+DAC”
treatments) and cells were harvested on day 5.  Total RNA was isolated using TRIzol Reagent (Invitrogen); 1 µg
was used for cDNA synthesis, and Gpat2 mRNA content was measured by qPCR.  Each treatment was performed
twice in triplicate.
In vitro methylation
The -156P Gpat2 promoter construct (3 µg/reaction) was incubated with 160 µM S-adenosylmethionine
(SAM) and 10 U of SssI methylase (CpG methyl transferase, M.SssI, New England Biolabs) (“methylated”) or
without enzyme (“unmethylated”) for 4 h at 37 °C, followed by a 20 min inactivation at 60 °C.  Plasmids were
purified  using  the  commercial  kit  Illustra  GFX PCR  DNA and  Gel  Band  Purification  Kit  (GE  Healthcare,  Life
sciences) and Lipofectamine 2000 (Invitrogen) was used to co-transfect with Renilla luciferase plasmid into CHO-
K1 cells.  The next day, cells were harvested and luminescence was measured using the Dual Luciferase Reporter
Assay System (Promega) and normalized to that of Renilla.
Germ cell purification
Germ cells  were isolated from testes  of  mice  at  11,  15  and 30 dpp as  described  [17].   Cells  were
incubated overnight at 34 °C in 4 % CO2 to allow Sertoli cells to adhere to the culture plate surface.  The germ-
cell enriched supernatant was removed, and centrifuged for 10 min at 800  g  at room temperature, and then
genomic DNA was extracted from the pellet.
Bisulfite treatment and sequencing
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Using DNeasy Blood & Tissue Kit (Qiagen), total DNA was purified from whole testis from 7 dpp mice and
from germ cells isolated from mouse testis at selected ages.  DNA purity and concentration were evaluated with
a NanoDrop spectrophotometer (Thermo Scientific).  For bisulfite treatment, 2 µg of genomic DNA was treated
employing  the  EpiTect  Bisulfite  Kit  (Qiagen).   PCR  reactions  were  performed  using  Taq  DNA  Polymerase
(Invitrogen); the protocol was similar to a nested PCR, but using the same set of primers.  For each reaction, 100
ng of bisulfite- converted DNA was used, and cycling conditions were: 2 min at 94 °C for initial denaturation,
followed by a touchdown step of 8 cycles of 45 s at 94 °C, 40 s at 64-56 °C, 1.5 min at 72 °C; 30 cycles of 45 s at
94 °C, 40 s at 56 °C, 1.5 min at 72 °C, and a final extension step of 6 m at 72 °C.  Five microliters of these PCR
products  were  then  used  as  templates  with  the  same  reaction  conditions.  Primers  used  were:  forward:
ATTGGTTGGTTTTTTAGTTGTTGAG; reverse: ATTCCACATCAATCCCTACCTAAC.  The products of interest (197 bp)
were gel purified with the Illustra GFX PCR DNA and Gel Band Purification Kit, ligated into pGEMT-Easy Vector
(Promega) and transformed into E. coli JM109 competent cells.  Insertion was confirmed by restriction enzyme
digestion, and 8 clones were chosen for sequencing.
Mouse testis subcellular fractionation and Immunoblotting
Testes from 7, 15, 20 and 35 dpp Balb/c mice were removed, rinsed with ice cold PBS, and submerged in
precooled buffer H (10 mM Hepes-KOH, pH 7.4, 0.25 M sucrose, 1 mM EDTA, 1 mM dithiothreitol, 0.002% v/v
protease inhibitor cocktail [general use] 1:6 [w/v]).  Testes were homogenized with 10 up-and-down strokes in a
motor-driven Teflon-glass vessel.  Large debris and nuclei were pelleted by centrifuging twice at 600  g for 5 min.
The  supernatant  (post-nuclear  homogenate)  was  centrifuged  for  10  min  at  10,000  g.   The  pellet  was  re-
suspended in 1 ml buffer H/g of testis and homogenized in a Dounce tissue grinder with a glass pestle to obtain
a mitochondria-enriched protein fraction.
One-hundred µg of the mitochondria-enriched protein fractions were separated on 8 or 12% SDS-PAGE,
transferred to a polyvinylidenedifluoride membrane (Bio-Rad), and probed with a 1:500 dilution of anti-GPAT2
antibody  [14] or  with  1:2000  of  the  anti-voltage  dependent  anion  channel  antibody  (anti-VDAC,  Affinity
Bioreagents),  as  loading  control.   Membranes  were  then  washed  extensively  and  probed  with  1:5000
horseradish  peroxidase-conjugated  goat  anti-rabbit  IgG  antibody  (Thermo-Pierce).   For  chemiluminescent
detection, the membranes were incubated with Super Signal detection kit (Thermo-Pierce).
RESULTS AND DISCUSSION
Gpat2 mRNA and protein are highly expressed in pachytene spermatocytes.
GPAT2 is expressed in male germ cells, particularly in primary spermatocytes, and its expression changes
during rat sexual development  [14].  The first round of spermatogenesis in mammals is characterized by the
synchronized  appearance of  particular  cell  types  at  different  stages  of  the spermatogenic  cycle  among the
seminiferous tubules, and this model was used to analyze differential gene expression during spermatogenesis
[18,19].  In mouse testis, only Sertoli cells and spermatogonia populate the seminiferous tubules until 10 dpp.
Subsequently, meiotic cells appear in the tubules:  at 11 dpp meiosis advances no further than the zygotene
stage, at 13 dpp to the early pachytene, at 15 dpp to the middle pachytene, at 18 dpp to the late pachytene, at
20 dpp to the round spermatid stage, and at 30 dpp spermatids have already reached the elongation phase and
sperm tail  accessory structures are being constructed.  After this period, synchrony is lost and all  stages of
spermatogenesis can be observed; however, apart from mature spermatozoa, pachytene spermatocytes and
round spermatids remain the most abundant germ cell types in seminiferous tubules [20].  In order to study the
relative expression of  Gpat2 mRNA during the first wave of spermatogenesis, total RNA was extracted from
testis at selected ages and expression was assessed by qPCR (Fig. 1A).  The mRNA content was low at 3 and 7
dpp,  and then increased,  reaching a  peak at  15 dpp,  after  which expression  dropped 50% to a  value that
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remained unchanged throughout adulthood.  To evaluate mRNA expression in the seminiferous tubules , in situ
mRNA hybridization (ISH) was performed on slides of mouse testis at 7, 15 and 30 dpp (Fig. 1C).  The label was
undetectable at 7 dpp, but positive staining was observed at 15 and 30 dpp.  Strong labelling was observed at 15
dpp and most  cells  populating the tubules  were positive  for  Gpat2 mRNA, except  for  the basal  germ cells
corresponding to spermatogonia.  In contrast, at 30 dpp the label was detected only in primary spermatocytes,
and mRNA expression was abruptly extinguished in the subsequent stages of spermatogenesis.  These results
are consistent with the analysis of microarray data collected from mouse testis, from fetal age to adulthood
(duplicates in 11, 12, 14, 16 and 18 days post coitum (dpc), 0, 3, 6, 8, 10, 14, 18, 20, 30 and 35 dpp) which shows
the time course of gene expression in murine testis  development (GEO Datasets:  GDS2098 and GSE12769).
Postnatal Gpat2 followed a similar profile than the one described in this work (Fig. 1B) and the microarray data
demonstrated that Gpat2 transcription is transiently active during embryonic development, reaching a peak at
15 dpc (Fig. 1B). 
To  verify  GPAT2  protein  expression,  Western  blot  analysis  and  immunohistochemistry  (IHC)  were
performed.   Western blot  showed that  the protein  expression peaked at  day  20,  consistent  with  the high
transcriptional rate at 15 dpp and the moderate transcription level at 20 dpp (Fig. 2A).  IHC was also performed
on mouse testes at 7, 15, 30 and 40 dpp (Fig. 2B).  Similar to the mRNA expression pattern, GPAT2 protein was
undetectable in 7 dpp testis, whereas a positive cytoplasmic signal was detected in testes from 15, 30 and 40
dpp mice.  Again, the distribution of the signal varied among the different germ cells within the seminiferous
tubules.  Strong staining was present in nearly all spermatocytes at 15 dpp (when pachytene spermatocytes
predominate).  This stain was localized to pachytene spermatocytes at 30 and 40 dpp and became more diffuse
in  later  stages  of  spermatogenesis  (Fig.  2B).   Thus,  Gpat2 mRNA expression  and  maximum GPAT2  protein
content within adult testis were restricted to pachytene spermatocytes.  This temporal-spatial profile suggests
that  GPAT2  plays  a  specific  role  in  spermatogenesis  and  that  strict  transcriptional  regulatory  mechanisms
operate to ensure an on-off expression pattern. The specific role for GPAT2 in spermatogenesis is suggested by
its involvement in the metabolism of a class of small non-coding RNAs called piRNAs that are predominantly
synthesized in germ cells; Gpat2 silencing in germline stem cells severely impaired primary piRNA production.  In
addition,  in  both germline  stem cells  and testis,  GPAT2 interacts  with  MILI  protein,  a  key  player  in  piRNA
metabolism [5].  The expression of piRNAs in mouse testis occurs at two distinct phases: pre-pachytene piRNAs
are  present  in  fetal  mice,  are  enriched  in  transposon  sequences,  and  are  synthesized  by  the  primary  and
secondary  (“ping-pong”)  pathways,  whereas  pachytene piRNAs originate  from discrete  genomic  loci  (piRNA
clusters), and their synthesis is independent of the ping-pong cycle  [21,22].  This expression profile of  Gpat2
reinforces the idea that GPAT2 functions in the primary piRNA biosynthesis pathway, since  Gpat2 expression
peaks not only when both pre-pachytene (embryonic) and pachytene piRNA are synthesized, but also occurs
simultaneously with Mili transcription(GEO Datasets: GDS2098 and GSE12769). 
Evaluation of Gpat2 minimal promoter
Epigenetic  modifications operate  with  trans-acting factors to  achieve transient  gene expression and
ensure the progression of spermatogenesis.  To identify the promoter region and study the regulatory elements
of the Gpat2 gene, the 5´ sequence flanking the transcription start site (TSS) (-1320 to translation start site) was
analyzed by online programs and applications,  such as  GPMiner,  Alibaba 2.0,  MethPrimer and Epigenomics
(NCBI) to recognize promoter elements such as the TATA box, CCAAT box and GpC islands.  The first intron was
included because in other genes, transcription factor binding sites or CpG islands are present in this  region
[16,23].  The Gpat2 promoter lacked a canonical TATA box and/or CAAT boxes in the 5´-flanking region, but a
CpG Island containing 10 CpG pairs was detected from -92 to +32.  These features are characteristic of a “CpG
island promoter” class (32).  To establish the region of minimal promoter activity, serial deletions of the putative
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promoter region were made, cloned into a luciferase reporter vector, and transiently transfected into CHO-K1
cells.  Basal transcription promoter activity was located between -156 and + 1 position (Fig. 3), a sequence that
contains 3 potential binding sites for Sp1 (which can initiate transcription when TATA box is absent [32]) and the
CpG island earlier  described.   These constructs were used to evaluate the influence of CpG methylation or
hormones on Gpat2 promoter activity.
Methylation status of Gpat2 promoter changes during the first wave of spermatogenesis
qPCR and in situ hybridization experiments during the first wave of spermatogenesis demonstrated that
Gpat2 mRNA  transcription  occurred  transiently  in  meiotic  cells;  expression  was  higher  in  pachytene
spermatocytes and abruptly decreased in subsequent stages of spermatogenesis.  We previously speculated that
ectopic GPAT2 expression in human cancer cells could be the consequence of epigenetic modifications  [13];
Thus, because epigenetic events are critical in regulating spermatogenesis, we asked whether these mechanisms
could regulate  Gpat2 transcription during mouse spermatogenesis.  To answer this question, we first assayed
the effect of chromatin modification reagents like the DNA methyltransferase inhibitor 5-aza-2-deoxycitidine
(DAC) and histone deacetylase inhibitor Trichostatin A (TSA) on Gpat2 transcription.  The murine cell line RAW
264.7  expresses  low  basal  levels  of  Gpat2, but  DAC  treatment  induced  Gpat2 expression  2-fold  (P<0.01),
whereas TSA treatment did not change mRNA expression.  The combination of both TSA and DAC treatments
enhanced  Gpat2 transcription  almost  6-fold  (Fig.  4A),  illustrating  synergistic  effects  on  Gpat2 transcription.
These experiments demonstrate that epigenetic changes such as hypomethylation, have a profound effect on
the rate of  Gpat2 transcription and that  the modifications  on histone acetylation become important when
methylation is low.  This result is consistent with microarray data showing that mice null for histone deacetylase-
2 highly up-regulate Gpat2 expression in the heart, a tissue in which Gpat2 is not constitutively expressed (GEO
profile  GDS2624 / 1456208_at /  Gpat2).  To determine whether methylation has the opposite effect on the
Gpat2 promoter, i.e. methylation is associated with Gpat2 silencing, the construct -156P containing the minimal
promoter  of  Gpat2 and the typical  CpG island located between -92 and +32,  was methylated  in  vitro and
luciferase activity was assayed (Fig. 4B).  Unmethylated construct activity was 20-fold higher than the internal
Renilla luciferase control, whereas methylated construct activity was lower than the internal control (10% of the
activity), suggesting that CpG methylation of the Gpat2 minimal promoter prevents transcription.  In summary,
whereas  DNA  hypomethylation  and  histone  acetylation  are  associated  with  high  transcription  rates,  DNA
methylation of the Gpat2 promoter prevents transcription.
To elucidate the methylation status of the Gpat2 promoter in vivo, total genomic DNA was purified from
7 dpp mouse testis and from germ cells isolated from mice at 11, 15 and 30 dpp.  At 7 dpp all the clones were
fully methylated, at 11 dpp a dramatic hypomethylation occurred in all the CpG pairs within the island, and at 15
dpp  all  clones  were  remethylated  (Fig.  4C).   Interestingly,  at  30  dpp  (when  primary  and  secondary
spermatocytes populate the tubules) the clones presented an on-off pattern: the CpG islands were either totally
unmethylated (37.5% of the clones) or fully methylated (62.5% of the clones).  To corroborate that promoter
methylation is the mechanism by which Gpat2 expression is repressed in other tissues, genomic DNA from liver
was  bisulfite-modified  and  the  Gpat2 CpG  Island  was  sequenced.   As  expected,  this  region  was  totally
methylated (data  not  shown).   Thus,  hypomethylation occurs  at  a  specific  time that is  consistent with the
initiation of meiosis (11 dpp) and precedes the maximum mRNA content detected at 15 dpp.  Taken together,
our data demonstrate that hypomethylation of the CpG Island present in the Gpat2 proximal promoter increases
gene  expression.   A  similar  correlation  between  methylation  status  of  the  proximal  promoter  and  gene
expression was also observed for another member of the piRNA pathway, the mouse  Miwi gene  [24], whose
temporal-spatial  expression  from  midpachytene  spermatocytes  to  round  spermatids  was  associated  with
hypomethylation  of  the  CpG  island  proximal  promoter.   Besides  the  spermatogenic  cells,  PIWI  genes  are
overexpressed  in  some  cancer  types  and  this  ectopic  expression  correlates  with  poorer  clinical  outcomes,
8
Ac
ce
pte
d M
a
us
cri
t
© 2015 The Author(s) Archiving permitted only in line with the archiving policy of Portland Press Limited. All other rights reserved.
suggesting that  PIWI genes  play a functional role in cancer biology  [25].  Epigenetic mechanisms ensure the
transient  expression of  the piRNA pathway genes at  specific  stages  of  spermatogenesis  and their  aberrant
expression in somatic cancer cells  [26].   Whether the expression of piRNAs and PIWI proteins in cancer is a
consequence or a cause of malignancy remains unclear.  However, it has been confirmed that the expression of
piRNA pathway genes is essential for the progression of spermatogenesis, i.e. the disruption of Miwi2 and Mili
genes cause a meiotic-progression defect, loss of germ cells, and sterility  [27,28].  In our previous work, we
confirmed not only the presence of human  GPAT2 in the cancer-derived cell  line MDA-MB-231, but also its
epigenetic  regulation  and  relevance  for  the  development  of  the  tumor  characteristics,  since  the  GPAT2
knockdown dramatically  decreased cellular  proliferation,  migration,  and in vivo  tumorigenicity.   In addition,
based on in silico information, high GPAT2 expression occurs in human breast cancer, melanoma, lung cancer,
and prostate cancer [13].
Gpat2 gene transcription is upregulated in vitro by retinoic acid.
The  varying  expression  of  GPAT2  protein  in  mouse  testis  motivated  us  to  search  for  hormone responsive
elements in its promoter region, particularly for those related to male sexual development and function.  The
promoter  region used for analysis  was the one selected for  the -1324P construct  and the on-line  program
Alibaba 2.1 [29] was used to predict transcription factor binding sites.  This program uses the TRANSFAC Public
Database, which contains an extensive compilation of published binding sites data for eukaryotic transcription
factors, their experimentally-proven binding sites, and regulated genes.  For this region the program predicted 7
glucocorticoid  response  elements,  9  retinoid  response  elements  (both  RXR  and  RAR),  3  estrogen  response
elements,  and 2 progesterone response elements.  We transfected the -1324P construct into cell  lines that
express  the  receptor  for  the  hormone that  was  being  evaluated.  We tested  Gpat2 promoter  activity  with
estradiol, corticosterone and ATRA/9cisRA in MCF7, CHO-K1 or TM4 cell lines, respectively.  No response was
observed with estradiol or corticosterone at the tested concentrations (refer to materials and methods) (data
not shown).  However, positive regulation was observed with two active vitamin A metabolites, 9cisRA and ATRA
(Fig. 5A, B).  We observed that 8 µM 9cisRA and 10 µM ATRA duplicated -1324P activity (Fig. 5A, B), but no
synergistic  effect  was observed when both retinoids were present  (data not shown).   All  the  Gpat2 active
promoter constructs were up-regulated by both isomers of RA.  Because both basal activity and the RA response
decreased downstream of the -156P construct and because RA-retinoid receptor complexes usually interact with
promoters near the transcription initiating site, it is possible that the predicted binding site for RARA at +89 in
the first intron might be involved in the Gpat2 promoter retinoid response.  (Fig. 5 C, D). 
Taking  into account  that  RA synthesized endogenously  by  premeiotic  spermatocytes  autonomously  induces
meiotic  initiation  by  controlling  the  RAR  dependent  expression  of  Stra8 [31] and  that  Gpat2 expression
correlates with the onset of prophase I of meiosis (at 13.5 dpc in ovaries (GEO profile GDS2223 / 1456208_at /
Gpat2) and at 15 dpp in testes (Fig. 1)) it could be speculated that RA may upregulate Gpat2 transcription in
vivo. Increasing evidence demonstrates that ATRA influences the epigenetic environment regulating both DNA
demethylation and histone acethylation/deacethylation [33-35].  Thus, the up-regulation of Gpat2 expression by
RA  might  be  a  consequence  of  promoter  demethylation,  histone  deacetylation,  and/or  canonical  trans-
activation.  Further experiments are required to validate this hypothesis.
Gpat2 expression is not induced when 3T3-L1 fibroblasts are differentiated to adipocytes
Although  Gpat2 was  initially  cloned by  its  sequence homology to  Gpat1,  an  enzyme that  promotes
triacylglycerol biosynthesis from endogenous and exogenous acyl-CoAs, primarily in liver [6], the role of GPAT2
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in lipid metabolism remains controversial.  We previously reported that LPA, the product of the GPAT-catalyzed
reaction, could not be detected when GPAT2 was overexpressed [14].  Overexpression of murine Gpat2 in CHO-
K1  cells  shows  no  increase  in  GPAT  activity  when  glycerol-3-phosphate  and  palmitoyl-CoA,  oleoyl-CoA  or
linoleoyl-CoA are used as substrates; in contrast, a 2-fold increase in a chloroform-soluble product is observed
when arachidonoyl-CoA is  used as  a  substrate,  although  this  increase is  due  to  phosphatidic  acid  with  no
accumulation of LPA [14].  Moreover, Gpat2 overexpression increases acylglycerol-3-phosphate acyltransferase
activity when both oleoyl-CoA and arachidonoyl-CoA are used as substrates [14].  These results strongly suggest
that GPAT2 may have an alternative acyltransferase activity.  Additionally, GPAT2 expression is low in liver and
adipose  tissue,  and  fasting  and  refeeding  do  not  alter  the  expression  of  murine  Gpat2 [10].   In  order  to
determine whether GPAT2 might play a role in lipogenesis, its expression was assessed in differentiating 3T3-L1
mouse fibroblasts.  No  Gpat2 mRNA induction was detected after cells differentiated into adipocytes (Fig. 6),
whereas, as expected, cells contained numerous large lipid droplets and a high content of TAG (data not shown).
This  result  is  consistent  with  the  fact  that  Gpat2  promoter  lacks  binding  sites  for  factors  that  regulate
lipogenesis, such as the ones belonging to SREBP1, ChREBP, or the PPAR family, and suggests that the primary
function of GPAT2 may be unrelated to the synthesis of triacylglycerol. 
In conclusion, the expression of GPAT2 during spermatogenesis is consistent with the requirement for
piRNA action and its transient expression is determined primarily by epigenetic modifications and possibly by
RA, a key regulator of meiosis entry.
ACKNOWLEDGMENTS 
We thank Mario Raul Ramos for the illustrations, Marianela Santana for her technical assistance and Dr.
Megumi Aita (UNC Molecular Neuroscience Core Facility) for her help with the in situ hybridization experiments.
MAM, EL, MPM and MRGB are members of the Carrera del Investigador Científico y Tecnológico and MBGF is a
fellow of CONICET, Argentina. 
DECLARATION OF INTEREST: 
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the
manuscript.
FUNDING: 
This  work  was  supported  by  NIH  Grants  1R03TW008698  (MRGB)  and  R01DK56598  (RAC),  USA;  PICT  2246
ANPCyT, PIP0310 CONICET and UNLP M168 (MRGB), UNLP PPIDM004 (MPM), Argentina.
AUTHOR CONTRIBUTIONS
Conceived and designed the experiments:  MPM, MRGB, MAM, MBGF.  Performed the experiments:  MBGF,
MAM,  EL,  MPM,  ERC.   Analyzed  the  data:  MBGF,  MRGB,  MPM,  MAM,  EL.   Contributed
reagents/materials/analysis tools: MRGB, RAC, MPM.  Wrote the paper: MPM, MBGF, MRGB, RAC, MAM.
REFERENCES
1. Griswold, M. D., Hogarth, C. A., Bowles, J. and Koopman, P. (2012) Initiating meiosis: the case for retinoic 
acid. Biol. Reprod. 86, 35
10
Ac
c
pte
d M
nu
sc
rip
t
© 2015 The Author(s) Archiving permitted only in line with the archiving policy of Portland Press Limited. All other rights reserved.
2. Hogarth, C. A. and Griswold, M. D. (2010) The key role of vitamin A in spermatogenesis. J. Clin. Invest 120, 
956-962
3. Rajender, S., Avery, K. and Agarwal, A. (2011) Epigenetics, spermatogenesis and male infertility. Mutat. 
Res. 727, 62-71
4. Aravin, A. A., Sachidanandam, R., Girard, A., Fejes-Toth, K. and Hannon, G. J. (2007) Developmentally 
regulated piRNA clusters implicate MILI in transposon control. Science. 316, 744-747
5. Shiromoto, Y., Kuramochi-Miyagawa, S., Daiba, A., Chuma, S., Katanaya, A., Katsumata, A., Nishimura, K., 
Ohtaka, M., Nakanishi, M., Nakamura, T., Yoshinaga, K., Asada, N., Nakamura, S., Yasunaga, T., Kojima-
Kita, K., Itou, D., Kimura, T. and Nakano, T. (2013) GPAT2, a mitochondrial outer membrane protein, in 
piRNA biogenesis in germline stem cells. RNA. 19, 803-810
6. Wendel, A. A., Lewin, T. M. and Coleman, R. A. (2009) Glycerol-3-phosphate acyltransferases: rate limiting 
enzymes of triacylglycerol biosynthesis. Biochim. Biophys. Acta 1791, 501-506
7. Jerkins, A. A., Liu, W. R., Lee, S. and Sul, H. S. (1995) Characterization of the murine mitochondrial glycerol-
3-phosphate acyltransferase promoter. J Biol Chem. 270, 1416-1421
8. Cao, J., Li, J. L., Li, D., Tobin, J. F. and Gimeno, R. E. (2006) Molecular identification of microsomal acyl-
CoA:glycerol-3-phosphate acyltransferase, a key enzyme in de novo triacylglycerol synthesis. Proc. Natl. 
Acad. Sci. U. S. A 103, 19695-19700
9. Shan, D., Li, J. L., Wu, L., Li, D., Hurov, J., Tobin, J. F., Gimeno, R. E. and Cao, J. (2010) GPAT3 and GPAT4 are
regulated by insulin-stimulated phosphorylation and play distinct roles in adipogenesis. J. Lipid Res. 51, 
1971-1981
10. Wang, S., Lee, D. P., Gong, N., Schwerbrock, N. M., Mashek, D. G., Gonzalez-Baro, M. R., Stapleton, C., Li, L.
O., Lewin, T. M. and Coleman, R. A. (2007) Cloning and functional characterization of a novel 
mitochondrial N-ethylmaleimide-sensitive glycerol-3-phosphate acyltransferase (GPAT2). Arch. Biochem. 
Biophys. 465, 347-358
11. Hofmann, O., Caballero, O. L., Stevenson, B. J., Chen, Y. T., Cohen, T., Chua, R., Maher, C. A., Panji, S., 
Schaefer, U., Kruger, A., Lehvaslaiho, M., Carninci, P., Hayashizaki, Y., Jongeneel, C. V., Simpson, A. J., Old, 
L. J. and Hide, W. (2008) Genome-wide analysis of cancer/testis gene expression. Proc. Natl. Acad. Sci. U. 
S. A. 105, 20422-20427
12. Whitehurst, A. W. (2014) Cause and consequence of cancer/testis antigen activation in cancer. Annu. Rev. 
Pharmacol. Toxicol. 54, 251-272
13. Pellon-Maison, M., Montanaro, M. A., Lacunza, E., Garcia-Fabiani, M. B., Soler-Gerino, M. C., Cattaneo, E. 
R., Quiroga, I. Y., Abba, M. C., Coleman, R. A. and Gonzalez-Baro, M. R. (2014) Glycerol-3-phosphte 
acyltransferase 2 behaves as a cancer testis gene and promotes growth and tumorigenicity in the breast 
cancer MDA-MB-231 cell line. PLoS. One. 9, e100896
14. Cattaneo, E. R., Pellon-Maison, M., Rabassa, M. E., Lacunza, E., Coleman, R. A. and Gonzalez-Baro, M. R. 
(2012) Glycerol-3-phosphate acyltransferase-2 is expressed in spermatic germ cells and incorporates 
arachidonic Acid into triacylglycerols. PLoS. One. 7, e42986
15. Coleman, R. A. and Bell, R. M. (1980) Selective changes in enzymes of the sn-glycerol 3-phosphate and 
dihydroxyacetone-phosphate pathways of triacylglycerol biosynthesis during differentiation of 3T3-L1 
preadipocytes. J. Biol. Chem. 255, 7681-7687
16. Kobayashi, T., Suzuki, M., Morikawa, M., Kino, K., Tanuma, S. and Miyazawa, H. (2015) Transcriptional 
regulation of Tal2 gene by all-trans retinoic acid (atRA) in P19 cells. Biol. Pharm. Bull. 38, 248-256
17. Boucheron, C. and Baxendale, V. (2012) Isolation and purification of murine male germ cells. Methods 
Mol. Biol. 825, 59-66
18. Margolin, G., Khil, P. P., Kim, J., Bellani, M. A. and Camerini-Otero, R. D. (2014) Integrated transcriptome 
analysis of mouse spermatogenesis. BMC. Genomics. 15, 39-15
19. Laiho, A., Kotaja, N., Gyenesei, A. and Sironen, A. (2013) Transcriptome profiling of the murine testis 
during the first wave of spermatogenesis. PLoS. One. 8, e61558
11
Ac
ce
pt
d M
an
us
cri
pt
© 2015 The Author(s) Archiving permitted only in line with the archiving policy of Portland Press Limited. All other rights reserved.
20. Soumillon, M., Necsulea, A., Weier, M., Brawand, D., Zhang, X., Gu, H., Barthes, P., Kokkinaki, M., Nef, S., 
Gnirke, A., Dym, M., de, M. B., Mikkelsen, T. S. and Kaessmann, H. (2013) Cellular source and mechanisms
of high transcriptome complexity in the mammalian testis. Cell Rep. 3, 2179-2190
21. Ku, H. Y. and Lin, H. (2014) PIWI proteins and their interactors in piRNA biogenesis, germline development 
and gene expression. Natl. Sci. Rev. 1, 205-218
22. Beyret, E., Liu, N. and Lin, H. (2012) piRNA biogenesis during adult spermatogenesis in mice is independent
of the ping-pong mechanism. Cell Res. 22, 1429-1439
23. Gaunt, S. J. and Paul, Y. L. (2014) Synergistic action in P19 pluripotential cells of retinoic acid and Wnt3a on
Cdx1 enhancer elements. Int. J. Dev. Biol. 58, 307-314
24. Hou, Y., Yuan, J., Zhou, X., Fu, X., Cheng, H. and Zhou, R. (2012) DNA demethylation and USF regulate the 
meiosis-specific expression of the mouse Miwi. PLoS. Genet. 8, e1002716
25. Moyano, M. and Stefani, G. (2015) piRNA involvement in genome stability and human cancer. J. Hematol. 
Oncol. 8, 38-0133
26. Friemel, C., Ammerpohl, O., Gutwein, J., Schmutzler, A. G., Caliebe, A., Kautza, M., von, O. S., Siebert, R. 
and Bens, S. (2014) Array-based DNA methylation profiling in male infertility reveals allele-specific DNA 
methylation in PIWIL1 and PIWIL2. Fertil. Steril. 101, 1097-1103
27. Carmell, M. A., Girard, A., van de Kant, H. J., Bourc'his, D., Bestor, T. H., de Rooij, D. G. and Hannon, G. J. 
(2007) MIWI2 is essential for spermatogenesis and repression of transposons in the mouse male 
germline. Dev. Cell. 12, 503-514
28. Kuramochi-Miyagawa, S., Kimura, T., Ijiri, T. W., Isobe, T., Asada, N., Fujita, Y., Ikawa, M., Iwai, N., Okabe, 
M., Deng, W., Lin, H., Matsuda, Y. and Nakano, T. (2004) Mili, a mammalian member of piwi family gene, 
is essential for spermatogenesis. Development. 131, 839-849
29. Wingender, E., Chen, X., Hehl, R., Karas, H., Liebich, I., Matys, V., Meinhardt, T., Pruss, M., Reuter, I. and 
Schacherer, F. (2000) TRANSFAC: an integrated system for gene expression regulation. Nucleic Acids Res. 
28, 316-319
30. Davis, J. C., Snyder, E. M., Hogarth, C. A., Small, C. and Griswold, M. D. (2013) Induction of spermatogenic 
synchrony by retinoic acid in neonatal mice. Spermatogenesis. 3, e23180
31. Raverdeau, M., Gely-Pernot, A., Feret, B., Dennefeld, C., Benoit, G., Davidson, I., Chambon, P., Mark, M. 
and Ghyselinck, N. B. (2012) Retinoic acid induces Sertoli cell paracrine signals for spermatogonia 
differentiation but cell autonomously drives spermatocyte meiosis. Proc. Natl. Acad. Sci. U. S. A. 109, 
16582-16587
32. Koubova, J., Menke, D. B., Zhou, Q., Capel, B., Griswold, M. D. and Page, D. C. (2006) Retinoic acid 
regulates sex-specific timing of meiotic initiation in mice. Proc. Natl. Acad. Sci. U. S. A. 103, 2474-2479
33. Rowling, M. J., McMullen, M. H. and Schalinske, K. L. (2002) Vitamin A and its derivatives induce hepatic 
glycine N-methyltransferase and hypomethylation of DNA in rats. J. Nutr. 132, 365-369
34. Lim, J. S., Park, S. H. and Jang, K. L. (2011) All-trans retinoic acid induces cellular senescence by up-
regulating levels of p16 and p21 via promoter hypomethylation. Biochem. Biophys. Res. Commun. 412, 
500-505
35. Heo, S. H., Kwak, J. and Jang, K. L. (2015) All-trans retinoic acid induces p53-depenent apoptosis in human 
hepatocytes by activating p14 expression via promoter hypomethylation. Cancer Lett. 362, 139-148
TITLES AND LEGENDS TO THE FIGURES
12
Ac
ce
pt
d M
an
us
cri
pt
© 2015 The Author(s) Archiving permitted only in line with the archiving policy of Portland Press Limited. All other rights reserved.
Figure 1. Gpat2 mRNA expression analysis during the first wave of spermatogenesis . (A) Gpat2 mRNA content
was analyzed in mouse testis at selected ages, and Gpat2 mRNA relative expression level for each sample was
normalized to both Gapdh and Rpl13A mRNA expression level.   (B) In silico analysis of pre and posnatal Gpat2
expression was performed using microarray information obtained from the public database GEO Profiles (NCBI).
(C) mRNA expression was assayed by in situ hybridization performed on slides of 7, 15 and 30 dpp mouse testis.
Arrows indicate positive reaction. Bar = 50 µM.
Figure 2.  GPAT2 protein expression analysis during the first wave of spermatogenesis.  (A) GPAT2 protein
content  was  analyzed  in  testis  mitochondrial  fractions  extracted  at  selected  ages  and  normalized  to  the
expression of the mitochondrial voltage dependent anion channel (VDAC).  Results are expressed as the average
of three independent experiments ± standard deviation. (B) Immunohistochemistry was assessed in 7, 15,30 and
40 dpp mouse testis (600X magnification).  Arrowheads indicate the germ cells showing a strong signal at 30 and
40 dpp. Bar: 50 µm.  Sg: spermatogonia, PS: pachytene spermatocytes, RS: round spermatids, ES: elongating
spermatids. Bar = 50 µM.
Figure 3. Basal promoter activity of the murine Gpat2 gene. Serial deletions of the putative promoter region
were made, cloned into luciferase vector and transiently transfected into CHO-K1 cells.  Relative luciferase
activity was normalized to the  Renilla luciferase internal control.  Results are expressed as the mean ±
standard deviation of replicates from two independent experiments.
Figure  4.  Epigenetic  mechanisms  involved  in  Gpat2 transcription  regulation.  (A)  The  effect  of  DNA
methyltransferase inhibitor 5-aza-2-deoxycitidine (DAC) and histone deacetylase inhibitor Trichostatin A (TSA)
on  Gpat2 transcription on the murine cell  line RAW 264.7 was assessed by qPCR and  Gpat2 mRNA relative
expression level for each sample was normalized to its  Gapdh and  Rpl13A mRNA expression level.  Bars with
different letters indicate statistical difference (P<0.01, one-way ANOVA and Tukey Test).  (B) In vitro methylation
of  the  Gpat2 minimal  promoter  construct  (-156P)  was  performed and  both  methylated  and  unmethylated
constructs were transfected into CHO-K1 cells.  Promoter activity was measured as luciferase activity relative to
the internal control  Renilla luciferase (** P<0.01, Student’s T-Test).  (C)  Total DNA from 7 dpp testes or from
isolated  germ  cells  from  11,  15  and  30  dpp  mouse  testes  was  purified  and  bisulfite-modified,  and  the
methylation  status  of  the  CpG  island  located  on  the  proximal  promoter  region  was  analyzed  after  PCR
amplification and sequencing.  The top bar shows a schematic representation of the location of CG pairs along
the fragment that was amplified: inverted triangles represent the CG pairs and the grey box represents the first
exon.  Average methylation status of each position among all the sequenced clones is represented by circles: a
black filled circle indicates  that  all  cytosines  were methylated at  that  position among all  the  clones (100%
methylated), and an empty circle indicates that all the cytosines were unmethylated at that position among all
the  clones  (0%  methylated).   Partially  black  circles  indicate  intermediate  percentages  of  clones  with  a
methylated cytosine at that position. The average methylation for each position is shown for 7, 11 and 15 dpp,
considering all the clones sequenced in each case (5-10 clones).  However, at 30 dpp 37 % of the clones were
almost fully unmethylated (10% or less methylated cytosines) and 63 % were fully methylated (70 % or more
methylated cytosines).  Thus, at this age the average methylation of each position is shown separately for the
unmethylated clones (37% of the clones) or the methylated ones (63% of the clones) to emphasize the co-
existence of two populations of germ cells in terms of GPAT2 promoter methylation status at 30 dpp.
Figure 5. Retinoic acid up-regulates  Gpat2 promoter activity. The -1324P construct was transfected into TM4
cells and the effect retinoids on Gpat2 promoter activity was evaluated with 2, 4, 6 and 8 µM of 9cisRA (A) and
2, 5, 10 and 20 µM of ATRA (B). Both isomers significantly increased promoter activity (one-way ANOVA and
Tukey Test), and 8 µM 9cisRA and 10 µM ATRA doubled it.  (C-D) The effect of 9cisRA and ATRA on Gpat2 active
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promoter constructs was tested: all were significantly up-regulated by both isomers of RA (Student’s T-test).
Results represent mean ± standard deviation of the replicates of two independent experiments.  ** P<0.01, *
P<0.05. Luciferase activity is expressed relative to that of Renilla internal control.
Figure 6. Gpat2 expression decreases during 3T3-L1 differentiation into adipocytes.  Gpat2 mRNA content was
evaluated by qPCR during 3T3-L1 mouse fibroblasts differentiation into adipocytes, and  Gpat2  mRNA relative
expression level for each sample was normalized to its  Gapdh and  Rpl13A mRNA expression level.  The black
arrow indicates the day when the differentiation cocktail was added.  Gpat2 mRNA content decreased after cell
differentiation. 
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